BS
Therapeutic Areas
Convergent Genomics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| UroAmp | Bladder Cancer (Minimal Residual Disease & Recurrence Monitoring) | Commercial |
| Drug | Indication | Phase |
|---|---|---|
| UroAmp | Bladder Cancer (Minimal Residual Disease & Recurrence Monitoring) | Commercial |